These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 30835559)

  • 21. The Predictive Value of PRECISE-DAPT Score for In-Hospital Mortality in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tanik VO; Cinar T; Arugaslan E; Karabag Y; Hayiroglu MI; Cagdas M; Rencuzogullari I; Uluganyan M
    Angiology; 2019 May; 70(5):440-447. PubMed ID: 30322265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a risk index for predicting short-term and long-term outcomes in patients with ST-elevation myocardial infarction.
    Shao C; Wang J; Li P; Yang J; Wang W; Wang Y; Zhao Y; Ni L; Tian J; Zhang K; Gao J; Tang YD; Yang Y
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():542-549. PubMed ID: 31922355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can we use plasma hyperosmolality as a predictor of mortality for ST-segment elevation myocardial infarction?
    Tatlisu MA; Kaya A; Keskin M; Uzman O; Borklu EB; Cinier G; Hayiroglu MI; Tatlisu K; Eren M
    Coron Artery Dis; 2017 Jan; 28(1):70-76. PubMed ID: 27608320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of SYNTAX score II efficacy with SYNTAX score and TIMI risk score for predicting in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction.
    Karabağ Y; Çağdaş M; Rencuzogullari I; Karakoyun S; Artaç İ; İliş D; Yesin M; Öterkus M; Gokdeniz T; Burak C; Tanboğa IH
    Int J Cardiovasc Imaging; 2018 Aug; 34(8):1165-1175. PubMed ID: 29541904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction.
    Leibundgut G; Gick M; Morel O; Ferenc M; Werner KD; Comberg T; Kienzle RP; Buettner HJ; Neumann FJ
    Clin Res Cardiol; 2016 May; 105(5):432-40. PubMed ID: 26563201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction.
    Li JW; Chen YD; Chen WR; You Q; Li B; Zhou H; Zhang Y; Han TW
    Cardiovasc Diabetol; 2017 Jun; 16(1):72. PubMed ID: 28587613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between CRP / Albumin ratio and in-stent restenosis development in patients with ST-segment elevation myocardial infarction.
    Aksu U; Gulcu O; Aksakal E; Kalkan K; Öztürk M; Korkmaz AF; Uslu A; Demirelli S
    J Clin Lab Anal; 2019 May; 33(4):e22848. PubMed ID: 30737841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
    Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction.
    Adatia K; Farag MF; Gue YX; Srinivasan M; Gorog DA
    Thromb Haemost; 2019 Nov; 119(11):1785-1794. PubMed ID: 31437861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the relationship between preprocedural C-reactive protein/albumin ratio and stent restenosis in patients with ST-segment elevation myocardial infarction.
    Rencuzogullari I; Karabağ Y; Çağdaş M; Karakoyun S; Seyis S; Gürsoy MO; Yesin M; Artaç İ; İliş D; Tanboğa İH
    Rev Port Cardiol (Engl Ed); 2019 Apr; 38(4):269-277. PubMed ID: 31104927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of the SYNTAX score II to predict 1-year outcome in patients with primary percutaneous coronary intervention.
    Wang G; Wang C; Zhang Y; Wang P; Ran C; Zhao L; Han L
    Coron Artery Dis; 2016 Sep; 27(6):483-9. PubMed ID: 27171362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ratio of systolic blood pressure to left ventricular end-diastolic pressure at the time of primary percutaneous coronary intervention predicts in-hospital mortality in patients with ST-elevation myocardial infarction.
    Sola M; Venkatesh K; Caughey M; Rayson R; Dai X; Stouffer GA; Yeung M
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):389-395. PubMed ID: 28303647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Neutrophil Percentage to Albumin Ratio as a New Predictor of In-Hospital Mortality in Patients with ST-Segment Elevation Myocardial Infarction.
    Cui H; Ding X; Li W; Chen H; Li H
    Med Sci Monit; 2019 Oct; 25():7845-7852. PubMed ID: 31628741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarction.
    Oh PC; Eom YS; Moon J; Jang HJ; Kim TH; Suh J; Kong MG; Park SD; Kwon SW; Suh SY; Lee K; Han SH; Ahn T; Kang WC
    BMC Cardiovasc Disord; 2020 Nov; 20(1):486. PubMed ID: 33208092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
    Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
    Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serial measurements of neutrophil gelatinase-associated lipocalin: prognostic value in patients with ST-segment elevation myocardial infarction treated with a primary percutaneous coronary intervention.
    Lim YM; Moon JY; Min D; Kim SH; Yang WI; Kim WJ; Sung JH; Kim IJ; Lim SW; Cha DH
    Coron Artery Dis; 2017 Dec; 28(8):690-696. PubMed ID: 28737526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kacprzak M; Zielinska M
    Int J Cardiol; 2016 Nov; 223():452-457. PubMed ID: 27544604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of eosinophil percentage and high-sensitivity C-reactive protein predicts in-hospital major adverse cardiac events in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Ye L; Bai HM; Jiang D; He B; Wen XS; Ge P; Zhang DY
    J Clin Lab Anal; 2020 Sep; 34(9):e23367. PubMed ID: 32441412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of long-term prognostic value of baseline SYNTAX and clinical SYNTAX scores in ST-segment elevation myocardial infarction patients with multivessel disease.
    Onuk T; Güngör B; İpek G; Karataş MB; Çanga Y; Akyüz Ş; Haci R; Karadeniz FÖ; Sungur A; Kaşikçioğlu H; Çam N
    Coron Artery Dis; 2016 Jun; 27(4):311-8. PubMed ID: 26945185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac and Noncardiac Causes of Long-Term Mortality in ST-Segment-Elevation Acute Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention.
    Yamashita Y; Shiomi H; Morimoto T; Yaku H; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Abe M; Nagao K; Shizuta S; Ono K; Kimura T;
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28073848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.